Clinical Study

Alliance A071801- Phase III Trial Of Post-Surgical Single Fraction Stereotactic Radiosurgery (Srs) Compared With Fractionated Srs (Fsrs) For Resected Metastatic Brain Disease

Posted Date: Sep 11, 2020

  • Investigator: Kyle Wang
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

This phase III trial studies how well single fraction stereotactic radiosurgery works compared with fractionated stereotactic radiosurgery in treating patients with cancer that has spread to the brain from other parts of the body and has been removed by surgery. The primary endpoint of this study will be to measure Surgical bed recurrence-free survival.


To Be Eligible: Must Have Three Or Fewer Unresected Brain Metastases, Unresected Lesions That Measure < 4.0 Cm, Resection Cavity That Measures < 5.0 Cm, No Prior Whole Brain Radiation Therapy, No Primary Germ Cell Tumor, Small Cell Carcinoma, Or Lymphoma,


Brain Cancer, Radiation

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.